Tresiba® now ready to be launched in Japan
13 February 2013 | By Novo Nordisk
Novo Nordisk announced that it has received approval of the price of Tresiba® (insulin degludec)...
List view / Grid view
News
Bristol-Myers Squibb enters a collaboration agreement with Reckitt Benckiser Group plc
12 February 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb has entered into an agreement with Reckitt Benckiser Group...
Teva Pharmaceuticals announces appointment of Dr. Arie Belldegrun to Board of Directors
11 February 2013 | By Teva Pharmaceutical Industries Ltd
Teva announced that Dr. Arie Belldegrun was appointed by the Board of Directors...
A microplate-based prion seeding assay is more sensitive and much faster than using animal models
11 February 2013 | By BMG LABTECH
Using a newly developed prion seeding assay researchers can now measure prion seeding...
Peter Rehse joins BioFocus as Senior Director, Structural Biology
11 February 2013 | By Zyme Communications
BioFocus announced that Dr. Peter Rehse has joined the company and will be based at Chesterford Park, near Cambridge, UK...
Novo Nordisk receives Complete Response Letter in the US for Tresiba® and Ryzodeg®
10 February 2013 | By Novo Nordisk
“We are convinced that Tresiba® and Ryzodeg® offer significant benefits...”
Pergamum AB announces a strategic collaboration with Cadila Pharmaceuticals Ltd
8 February 2013 | By Cision
Pergamum AB and Cadila Pharmaceuticals Ltd announced a strategic collaboration...
Amgen announces call for nominations for 2013 Breakaway from Cancer® Champions
8 February 2013 | By Amgen
Four inspirational individuals making a positive impact for those affected by Cancer...
New Phase 3 data reinforce long-lasting protection from bleeding for patients with Hemophilia A and B
8 February 2013 | By Biogen Idec
Biogen Idec and Swedish Orphan Biovitrum released data...
Gilead Sciences completes acquisition of YM BioSciences
8 February 2013 | By
Gilead Sciences, Inc. announced that it has completed its acquisition of YM BioSciences Inc...
BioCity Scotland announced as UK hub for major European drug discovery project
7 February 2013 | By University of Dundee
"We are absolutely delighted that the European Lead Factory will be co-located in Scotland..."
€196 million Pan-European drug discovery platform launched
7 February 2013 | By Innovative Medicines Initiative (IMI)
Large pharmaceutical companies join forces with small and medium-sized enterprises (SMEs) and academia in an IMI-supported public private partnership (PPP) to enhance early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs...
Nottingham in €196 million European drug discovery drive
7 February 2013 | By The University of Nottingham
Pioneering chemists from The University of Nottingham are taking part in the biggest-ever European research programme...
Tecan’s multimode readers offer staying power for biomolecular research
7 February 2013 | By kdm communications limited
Scientists at the University of Toronto, Canada, have chosen generations of Tecan microplate readers to monitor...
Amgen Outlines Long-Term Strategy
7 February 2013 | By Amgen
Amgen outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City...
